Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Co‐shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome
Teodor T. Postolache, Laura del Bosque‐Plata, Serge Jabbour, et al.
American Journal of Medical Genetics Part B Neuropsychiatric Genetics (2019) Vol. 180, Iss. 3, pp. 186-203
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

Comorbid Major Depressive Disorder in Schizophrenia: A Systematic Review and Meta-Analysis
Damien Etchecopar‐Etchart, Théo Korchia, Anderson Loundou, et al.
Schizophrenia Bulletin (2020) Vol. 47, Iss. 2, pp. 298-308
Open Access | Times Cited: 79
Mortality gap and physical comorbidity of people with severe mental disorders: the public health scandal
Andrea Fiorillo, Norman Sartorius
Annals of General Psychiatry (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 71
Association of Youth Depression With Subsequent Somatic Diseases and Premature Death
Marica Leone, Ralf Kuja‐Halkola, Amy Levál, et al.
JAMA Psychiatry (2020) Vol. 78, Iss. 3, pp. 302-302
Open Access | Times Cited: 65
Mechanisms Underlying the Comorbidity of Schizophrenia and Type 2 Diabetes Mellitus
Yutaka Mizuki, Shinji Sakamoto, Yuko Okahisa, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 24, Iss. 5, pp. 367-382
Open Access | Times Cited: 62
Shared genetics of psychiatric disorders and type 2 diabetes:a large-scale genome-wide cross-trait analysis
Hui Ding, Minyao Xie, Jinyi Wang, et al.
Journal of Psychiatric Research (2023) Vol. 159, pp. 185-195
Closed Access | Times Cited: 16
Phenome-wide investigation of bidirectional causal relationships between major depressive disorder and common human diseases
Wen-xi Sun, Ancha Baranova, Dongming Liu, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Antidiabetes Agents and Incident Depression: A Nationwide Population-Based Study
Lars Vedel Kessing, Helene C. W. Rytgaard, Claus Thorn Ekstrøm, et al.
Diabetes Care (2020) Vol. 43, Iss. 12, pp. 3050-3060
Open Access | Times Cited: 48
A chromosomal connectome for psychiatric and metabolic risk variants in adult dopaminergic neurons
Sergio Espeso‐Gil, Tobias Halene, Jaroslav Bendl, et al.
Genome Medicine (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 40
Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction
Kah Kheng Goh, Cynthia Yi-An Chen, Tzu‐Hua Wu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7092-7092
Open Access | Times Cited: 24
Association between type 2 diabetes and depressive symptoms after a 1-year follow-up in an older adult Mediterranean population
Isabel Baenas, Lucía Camacho‐Barcia, Roser Granero, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 6, pp. 1405-1418
Open Access | Times Cited: 5
Conceptualization and characterization of “primary” and “secondary” cognitive impairment in schizophrenia
Antonio Vita, Gabriele Nibbio, Sergio Barlati
Psychiatry Research (2024) Vol. 340, pp. 116126-116126
Open Access | Times Cited: 5
Integrated Analysis of Summary Statistics to Identify Pleiotropic Genes and Pathways for the Comorbidity of Schizophrenia and Cardiometabolic Disease
Hao Liu, Yang Sun, Xinxin Zhang, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 33
Gut microbiota and microbiome in schizophrenia
Jerzy Samochowiec, Błażej Misiak
Current Opinion in Psychiatry (2021) Vol. 34, Iss. 5, pp. 503-507
Closed Access | Times Cited: 32
The prevalence and clinical correlates of metabolic syndrome and cardiometabolic alterations in 430 drug-naive patients in their first episode of schizophrenia
Xiaoe Lang, Qinqin Liu, Han-liu Fang, et al.
Psychopharmacology (2021) Vol. 238, Iss. 12, pp. 3643-3652
Closed Access | Times Cited: 28
The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management: a narrative review focusing on principal risk modifiers
Amedeo Lonardo
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 10, pp. 891-911
Closed Access | Times Cited: 12
Paternal immune activation by Poly I:C modulates sperm noncoding RNA profiles and causes transgenerational changes in offspring behavior
Elizabeth A. Kleeman, Sonali N. Reisinger, Pranav Adithya, et al.
Brain Behavior and Immunity (2023) Vol. 115, pp. 258-279
Closed Access | Times Cited: 12
Gender differences in prevalence and associated factors of metabolic syndrome in first-treatment and drug-naïve schizophrenia patients
Kuan Zeng, Shuo Wang, Lin Zhang, et al.
Annals of General Psychiatry (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Noncanonical EEG-BOLD coupling by default and in schizophrenia
Michael Jacob, Brian J. Roach, Daniel H. Mathalon, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Association between the COX-2 rs689466 polymorphism and antipsychotic treatment: Impact on HDL cholesterol changes in clozapine-treated psychosis patients
Sergej Nadalin, Ivan Ljoka, Aleksandar Savić, et al.
Prostaglandins Leukotrienes and Essential Fatty Acids (2025), pp. 102665-102665
Closed Access
Clinical Characterisation of the Co-Occurrence of Mental and Physical Disorders
R. I. G. Holt
(2025), pp. 127-160
Closed Access
Managing co-occurring physical disorders in mental health care
Delia Cimpean Hendrick, Robert E. Drake
Oxford University Press eBooks (2025), pp. 233-242
Closed Access
Investigating the association of the plasma lipidomic profile with cognitive performance and genetic risk in the PsyCourse study
Mojtaba Oraki Kohshour, Sergi Papiol, Anna Tkachev, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access
Prolactin (PRL): Physiology and Physiopathology in Depression Subtypes and Metabolic Disorders and Their Comorbidity
Michele Perrelli, Claudia Gragnoli
(2025), pp. 1-21
Closed Access
Sex differences in metabolic disorder patterns of first-episode drug-naive patients with schizophrenia
Yongjie Zhou, Xinxin Song, Yanhong Guo, et al.
Psychoneuroendocrinology (2020) Vol. 124, pp. 105061-105061
Closed Access | Times Cited: 31
The Wistar Kyoto Rat: A Model of Depression Traits
Eva E. Redei, Mallory E. Udell, Leah C. Solberg Woods, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 9, pp. 1884-1905
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top